Akouos

+$0.05 (+1.86%) Today
$0.00 (0.00%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Akouos and other ETFs, options, and stocks.

About AKUS

Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene.

CEO
Emmanuel J. Simons
Employees
103
Headquarters
Boston, Massachusetts
Founded
2016

AKUS Key Statistics

Market cap
94.88M
Price-Earnings ratio
—
Dividend yield
—
Average volume
94.74K
High today
$2.77
Low today
$2.56
Open price
$2.73
Volume
67.15K
52 Week high
$15.26
52 Week low
$2.32

AKUS Earnings

-$0.85
-$0.57
-$0.28
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure